Literature DB >> 24666210

Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testing.

Wan C Tan1, Jean Bourbeau, Denis O'Donnell, Shawn Aaron, Francois Maltais, Darcy Marciniuk, Paul Hernandez, Robert Cowie, Kenneth Chapman, A Sonia Buist, Don Sin, J Mark Fitzgerald.   

Abstract

BACKGROUND: The assurance of high-quality spirometry testing remains a challenge.
METHODS: Spirometry training consisted of standardized coaching followed by certification for 35 spirometry-naïve and 9 spirometry-experienced research assistants. Spirometry was performed before and after bronchodilator (BD) in random population samples of 5176 people aged 40 years and older from 9 sites in Canada. using the hand-held EasyOne spirometer (ndd Medical Technologies Inc., Andover, MA, USA). Pulmonary function quality assurance with over reading was conducted centrally in Vancouver: spirograms were reviewed and graded according to ATS/ERS standards with prompt feedback to the technician at each site. Descriptive statistics were calculated for manoeuvre acceptability and repeatability variables. A logistic regression model was constructed for the predictors of spirometry quality success.
RESULTS: 95% of test sessions achieved pre-determined quality standards for back extrapolated volume (BEV), time to peak flow (PEFT) and end of test volume (EOTV). The mean forced expiratory time (FET) was 11.2 seconds. Then, 90% and 95% of all manoeuvres had FEV1 and FVC that were repeatable within 150 ml and 200 ml respectively. Test quality was slightly better for post-BD test sessions compared with pre-BD for both groups of research assistants. Independent predictors of acceptable test quality included participant characteristics: female sex, younger age, greater BD responsiveness; but not study site or prior experience in completing spirometry by the technologist.
CONCLUSIONS: Good quality spirometry tests are attainable in large multicenter epidemiological studies by trained research assistants, irrespective of their prior experience in spirometry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24666210     DOI: 10.3109/15412555.2013.822857

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  8 in total

1.  Effect of a preoperative single-dose steroid on pulmonary function and postoperative symptoms after modified radical mastectomy: results of a randomized clinical trial.

Authors:  Jorge Jiménez-Tornero; Ana Olivia Cortés-Flores; Mariana Chávez-Tostado; Gilberto Morgan-Villela; Carlos Zuloaga-Fernández Del Valle; Raymundo Zuloaga-Fernández Del Valle; Luis Alberto García-González; Vanesa Sarahí Fernández-Avalos; Roberto Carlos Miranda-Ackerman; Andrea Socorro Alvarez-Villaseñor; Gabriela Ambriz-González; Francisco José Barbosa-Camacho; Clotilde Fuentes-Orozco; Vianca Seleste Contreras-Cordero; Alejandro González-Ojeda
Journal:  Gland Surg       Date:  2020-10

2.  High quality standards for a large-scale prospective population-based observational cohort: Constances.

Authors:  Fabrice Ruiz; Marcel Goldberg; Sylvie Lemonnier; Anna Ozguler; Evelyne Boos; Alain Brigand; Violaine Giraud; Thierry Perez; Nicolas Roche; Marie Zins
Journal:  BMC Public Health       Date:  2016-08-25       Impact factor: 3.295

3.  The Ottawa Citizen Engagement and Action Model (OCEAM): A Citizen engagement Strategy Operationalized Through The Participatory Research in Ottawa, Management and Point-of-care of Tobacco (PROMPT) Study: A Community Based Participatory Action Research Project in Inner City Ottawa.

Authors:  Smita Pakhale; Tina Kaur; Kelly Florence; Tiffany Rose; Robert Boyd; Joanne Haddad; Donna Pettey; Wendy Muckle; Mark Tyndall
Journal:  Res Involv Engagem       Date:  2016-05-21

4.  Assessing community (peer) researcher's experiences with conducting spirometry and being engaged in the 'Participatory Research in Ottawa: Management and Point-of-care for Tobacco-dependence' (PROMPT) project.

Authors:  Catherine B Charron; Alzahra Hudani; Tina Kaur; Tiffany Rose; Kelly Florence; Sadia Jama; Smita Pakhalé
Journal:  Res Involv Engagem       Date:  2018-12-01

5.  Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.

Authors:  Brian L Graham; Irene Steenbruggen; Martin R Miller; Igor Z Barjaktarevic; Brendan G Cooper; Graham L Hall; Teal S Hallstrand; David A Kaminsky; Kevin McCarthy; Meredith C McCormack; Cristine E Oropez; Margaret Rosenfeld; Sanja Stanojevic; Maureen P Swanney; Bruce R Thompson
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

6.  The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study.

Authors:  Clarus Leung; Jean Bourbeau; Don D Sin; Shawn D Aaron; J Mark FitzGerald; François Maltais; Darcy D Marciniuk; Denis O'Donnell; Paul Hernandez; Kenneth R Chapman; Brandie Walker; Jeremy D Road; Liyun Zheng; Carl Zou; James C Hogg; Wan C Tan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-12

7.  Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients.

Authors:  Bulent Enis Sekerel; Hilal Unsal; Umit Murat Sahiner; Ozge Uysal Soyer; Ebru Damadoglu; Gul Karakaya; Ali Fuat Kalyoncu
Journal:  J Asthma Allergy       Date:  2022-02-15

8.  Quality and learning aspects of the first 9000 spirometries of the LifeGene study.

Authors:  Mikaela Qvarfordt; Martin Anderson; Magnus Svartengren
Journal:  NPJ Prim Care Respir Med       Date:  2018-02-19       Impact factor: 2.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.